Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2023 Mar 13;87(3):50. doi: 10.1007/s00245-022-09963-z

Functional Law of Large Numbers and PDEs for Epidemic Models with Infection-Age Dependent Infectivity

Guodong Pang 1,, Étienne Pardoux 2
PMCID: PMC10009871  PMID: 36937240

Abstract

We study epidemic models where the infectivity of each individual is a random function of the infection age (the elapsed time since infection). To describe the epidemic evolution dynamics, we use a stochastic process that tracks the number of individuals at each time that have been infected for less than or equal to a certain amount of time, together with the aggregate infectivity process. We establish the functional law of large numbers (FLLN) for the stochastic processes that describe the epidemic dynamics. The limits are described by a set of deterministic Volterra-type integral equations, which has a further characterization using PDEs under some regularity conditions. The solutions are characterized with boundary conditions that are given by a system of Volterra equations. We also characterize the equilibrium points for the PDEs in the SIS model with infection-age dependent infectivity. To establish the FLLNs, we employ a useful criterion for weak convergence for the two-parameter processes together with useful representations for the relevant processes via Poisson random measures.

Keywords: Functional law of large numbers, Deterministic Volterra integral equations, PDEs, Non-Markovian epidemic models, Infection-age dependent (varying) infectivity, Poisson random measure, SIR, SIS, Equilibrium in the SIS model

Introduction

Kermack and McKendrick pioneered the introduction of PDE models to describe the epidemic dynamics for models with infection-age dependent (variable) infectivity in 1932 [19]. The underlying assumption of their model is that the infectious periods have a general distribution with density which is modeled through an infection-age dependent recovery rate, the infectious individuals having an infection-age dependent infectivity, and the recovered ones a recovery-age susceptibility. In the present paper, we do not consider possible loss of immunity. We defer to a work in preparation the study of variable susceptibility. In the present paper, we mainly consider the SIR model (although we can allow for an exposed period, as will be explained below) and the SIS model. This work is a continuation of our first work on non-Markov epidemic models [25], and our work on varying infectivity models [10], see also [24]. In those papers, we show that certain deterministic Volterra type integral equations are Functional Law of Large Numbers (FLLN) limits of adequate individual based stochastic models. An important feature of our stochastic models is that they are non-Markov (since the infectious duration need not have an exponential distribution), and as a result the limiting deterministic models are equations with memory. Note that as early as in 1927, Kermack and McKendrick introduced in their seminal paper [18] a SIR model with both infection-age dependent infectivity and infection-age dependent recovery rate, the latter allowing the infectious period to have an arbitrary absolutely continuous distribution (the infection-age dependent recovery rate is the hazard rate function of the infectious period). One part of that paper is devoted to the simpler case of constant rates, and apparently most of the later literature on epidemic models has concentrated on this special case, which leads to simpler ODE models, the corresponding stochastic models being Markov models, at the price of the models being less realistic. For example, the recent studies in Covid-19 [11, 30] indicates that using the ODE models can lead to an underestimation of the basic reproduction number R0.

In this paper, we go back to the original model of Kermack and McKendrick [18], with two new aspects. First, as in our previous publications, we want to obtain the deterministic model as a law of large numbers limit of stochastic models, and second, we distribute the various infected individuals at time t according to their infection-age, and establish a PDE for the “density of individuals” being infected at time t, with infection-age x.

In our stochastic epidemic model, each individual is associated with a random infectivity, which varies as a function of the age of infection (elapsed time since infection). The random infectivity functions, effective during the infected period, are assumed to be i.i.d. for the various individuals, and will also generate the infectious period. The infectivity function is assumed to be càdlàg with a given number of discontinuities, and upper bounded by a deterministic constant. In particular, the law of the infectious period can be completely arbitrary. Our modeling approach allows the random infectivity functions to have an initial period of time during which they take zero values, corresponding to the exposed period. Thus our model generalizes both the classical SIR and SEIR models. To describe the epidemic dynamics of the model, we use a (two-parameter or measure-valued) stochastic process that tracks at each time t the number of individuals that have been infected for a duration less than or equal to a certain amount of time x, and an associated aggregate infectivity process which at each time t sums up the infectivities of all individuals who are infected. From these processes, we can describe the cumulative infection process, the total number of infected individuals as well as the number of recovered ones at each time. We use similar processes to describe the epidemic dynamics for the SIS model with infection-age dependent infectivity.

In the asymptotic regime of a large population (i.e., as the total population size N tends to infinity), we establish the FLLN for the epidemic dynamics. The limits are characterized by a set of deterministic Volterra-type integral equations (Theorem 2.1). Under certain regularity conditions, the density function of the two-parameter (calendar time and infection age) limit process can be described by a one-dimensional PDE (Proposition 3.1 in the case where the distribution of the infectious period is absolutely continuous). Its solution is characterized with a boundary condition satisfying a one-dimensional Volterra-type integral equation. The aggregate infectivity limit process can be described by an integral of the average infectivity function with respect to the limiting two-parameter infectious process (Corollary 3.1, see also Remark 3.4). For the classical SIR model, we recover the well-known linear PDE first proposed by Kermack and McKendrick [19]. We further derive the PDE model when the distribution of the infectious period need not be absolutely continuous (Proposition 3.2 and see also Corollary 3.3 where the infectious periods are deterministic). These PDE models are new to the literature of epidemiology. For the SIS model, we also describe the limiting epidemic dynamics and the PDE representations, and derive the equilibrium quantities associated with the PDE and total count limit (assuming convergence to the equilibria).

Literature Review

Non-Markov stochastic epidemic models lead (via the FLLN) to deterministic models, which are either low dimensional evolution equation with memory (i.e., Volterra type integral equations), or else coupled ODE/PDE models, where the two variables are the time and the age of infection (time since infection). The first paper of Kermack and McKendrick [18] adopts the first point of view, and the two next [19, 20] the second one. In our recent previous work on this topic [10, 25], we have adopted the first description. The goal of the present paper is to show that in the limit of a large population, our stochastic individual based model with age of infection dependent infectivity and recovery rate converges as well to a limiting system of PDE/ODEs.

While the general model from [18] was largely neglected until rather recently, most of the literature concentrating on the particular case of constant rates, there has been since the 1970s some papers considering infection-age dependent epidemic models, see in particular [14]. More recently, several papers have introduced coupled PDE/ODE models for studying age of infection dependent both infectivity and recovery rate, see in particular [6, 16, 22, 28, 29] and Chapter 13 in [23]. In [8], the authors consider a stochastic epidemic model with contract-tracing, tracking the infection duration since detection for each individual, and use a measure-valued Markov process to describe the epidemic dynamics. They prove a FLLN with a large population and establish a PDE limit, and also prove a FCLT with a SPDE limit process. Since the beginning of the Covid-19 pandemic, a huge number of papers have been produced, with various models of the propagation of this disease. Most of them use ODE models, but a few, notably [9, 12, 13, 17] consider age of infection dependent infectivity, and possibly recovery rate. The last two derive the ODE/PDE model as a law of large numbers limit of stochastic individual based models. The article [12] considers a branching process approximation of the early phase of an epidemic, and the way they model the dependence of the rate of infection with respect to the age of infection is less general than in our model. Recently, the authors in [9] study contact tracing in an individual-based epidemic model via an “infection graph" of the population, and prove the local convergence of the random graph to a Poisson marked tree and a Kermack and McKendrick type of PDE limit for the dynamics by tracking the infection age.

Note also that one way that many authors have chosen in order to improve the realism of ODE models is by increasing the number of compartments. For instance, dividing the infectious compartment into subcompartments, each one corresponding to a different infection rate, is a way to introduce a (piecewise constant) infection age dependent infectivity. In a way, this means approaching a non-Markov process of a given dimension by a higher dimensional Markov process, or approaching a system differential equations with memory by a higher dimensional system of ODEs. In the present paper, we show that the system of integral equations with memory introduced in our earlier work [25] can be replaced by an ODE/PDE system, i.e., an infinite dimensional differential equation. At the level of the stochastic finite population model, this means replacing a non-Markov finite dimensional Markov process by a high dimensional process (whose dimension is bounded by the total population size N, which tends to infinity in our asymptotic). See Remarks 3.2 and 3.7 below.

We also like to mention the relevant work in queueing systems where the elapsed service times are tracked using two-parameter or measure-valued processes. The most relevant to us are the infinite-server (IS) queueing models studied in [1, 26, 27], where FLLN and FCLT are established for two-parameter processes to tracking elapsed and residual service times. However, the proof techniques we employ in this paper are very different from those papers. Here we exploit the representations with Poisson random measures and use a new weak convergence criterion (Theorem 5.1). In addition, despite similarities with the IS queueing models, the stochastic epidemic models have an arrival (infection) process that depend on the state of the system. As a consequence, the limits in the FLLNs result in PDEs while the IS queueing models do not.

Organization of the Paper

The paper is organized as follows. In Sect. 2, we describe the stochastic epidemic model with infection-age dependent infectivity, and state the FLLN. In Sect. 3, we present the PDE models from the FLLN limits, and also characterize the solution properties of the PDEs. The limits and PDE for the SIS model are presented in Sect. 4, which also considers the equilibrium behavior. In Sect. 5, we prove the FLLN. The Appendix gives the proof of the convergence criterion in Theorem 5.1.

Notations

All random variables and processes are defined on a common complete probability space (Ω,F,P). The notation means convergence in distribution. We use 1{·} for the indicator function, and occasionally use 1{·} for better readability. Throughout the paper, N denotes the set of natural numbers, and Rk(R+k) denotes the space of k-dimensional vectors with real (nonnegative) coordinates, with R(R+) for k=1. For x,yR, we denote xy=min{x,y} and xy=max{x,y}. Let D=D(R+;R) denote the space of R-valued càdlàg functions defined on R+. Throughout the paper, convergence in D means convergence in the Skorohod J1 topology, see Chapter 3 of [4]. Also, Dk stands for the k-fold product equipped with the product topology. Let C be the subset of D consisting of continuous functions. Let C1 consist of all differentiable functions whose derivative is continuous. Let D denote the set of increasing functions in D. Let DD=D(R+;D(R+;R)) be the D-valued D space, and the convergence in the space DD means that both D spaces are endowed with the Skorohod J1 topology. The space CC is equivalent to C(R+2;R+). Let C(R+2;R+) denote the space of continuous functions from R+2 into R+, which are increasing as a function of their second variable. For any increasing càdlàg function F(·):R+R+, abusing notation, we write F(dx) by treating F(·) as the positive (finite) measure on R+ whose distribution function is F. For any R-valued càdlàg function ϕ(·) on R+, the integral abϕ(x)F(dx) represents (a,b]ϕ(x)F(dx) for a<b.

Model and FLLN

Model Description

We consider an epidemic model in which the infectivity rate depends on the age of infection (that is, how long the individuals have been infected). Specifically, each individual i is associated with an infectivity process λi(·), and we assume that these random functions are i.i.d.. Let ηi=inf{t>0:λi(r)=0,rt} be the infected period corresponding to the individual that gets infected at time τiN. The ηi’s are i.i.d., with a cumulative distribution function (c.d.f.) F. Let Fc=1-F.

Individuals are grouped into susceptible, infected and recovered ones. Let the population size be N and SN(t), IN(t) and RN(t) denote the numbers of the susceptible, infected and recovered individuals at time t. We have the balance equation: N=SN(t)+IN(t)+RN(t), t0. Assume that SN(0)>0, IN(0)>0 and RN(0)=0. Let IN(t,x) be the number of infected individuals at time t that have been infected for a duration less than or equal to x. Note that for each t, IN(t,x) is nondecreasing in x, which is the distribution of IN(t) over the infection-ages. Let AN(t) be the cumulative number of newly infected individuals in (0, t], with the infection times {τiN:iN}.

Let {τj,0N,j=1,,IN(0)} be the times at which the initially infected individuals at time 0 became infected. Then τ~j,0N=-τj,0N, j=1,,IN(0), represent the amount of time that an initially infected individual has been infected by time 0, that is, the age of infection at time 0. WLOG, assume that 0>τ1,0N>τ2,0N>>τIN(0),0N (or equivalently 0<τ~1,0N<τ~2,0N<<τ~IN(0),0N). Set τ~0,0N=0. We define IN(0,x)=max{j0:τ~j,0Nx}, the number of initially infected individuals that have been infected for a duration less than or equal to x at time 0. Assume that there exists 0x¯< such that IN(0)=IN(0,x¯) a.s.

Each initially infected individual j=1,,IN(0), is associated with an infectivity process λj0(·), and we assume that they are also i.i.d., with the same law as λi(·). This is reasonable since it is for the same disease, and the infectivity for the initially and newly infected individuals with the same infection age should have the same law. The infectivity processes take effect at the epochs of infection. For each j, let ηj0=inf{t>0:λj0(τ~j,0N+r)=0,rt} be the remaining infectious period, which depends on the elapsed infection time τ~j,0N, but is independent of the elapsed infection times of other initially infected individuals. In particular, the conditional distribution of ηj0 given that τ~j,0N=s>0 is given by

Pηj0>t|τ~j,0N=s=Fc(t+s)Fc(s),fort,s>0. 2.1

Note that the ηj0’s are independent but not identically distributed.

For an initially infected individual j=1,,IN(0), the infection age is given by τ~j,0N+t for 0tηj0, during the remaining infectious period. For a newly infected individual i, the infection age is given by t-τiN, for τiNtτiN+ηi during the infectious period. Note that λi(·) and λj0(·) are equal to zero on R-.

The aggregate infectivity process at time t is given by

IN(t)=j=1IN(0)λj0τ~j,0N+t+i=1AN(t)λit-τiN,t0. 2.2

(Note that the notation IN was used for the infectivity process in [10, 24].) The instantaneous infection rate at time t can be written as

ΥN(t)=SN(t)NIN(t),t0. 2.3

The counting process of newly infected individuals AN(t) can be written as

AN(t)=0t01uΥN(s-)Q(ds,du), 2.4

where Q is a standard Poisson random measure on R+2 (see, e.g., [7, Chapter VI]).

Among the initially infected individuals, the number of individuals who have been infected for a duration less than or equal to x at time t is equal to

I0N(t,x)=j=1IN(0)1ηj0>t1τ~j,0N(x-t)+=j=1IN(0,(x-t)+)1ηj0>t,t,x0, 2.5

Recall the age limit of the initially infected individuals x¯ at time zero. Thus, the number of the initially infected individuals that remain infected at time t can be written as

I0N(t)=I0N(t,x¯+t),t0. 2.6

Among the newly infected individuals, the number of individuals who have been infected for a duration less than or equal to x at time t is equal to

I1N(t,x)=i=1AN(t)1(t-x)+<τiNt1τiN+ηi>t=i=1AN(t)1τiN+ηi>t-i=1AN((t-x)+)1τiN+ηi>t=i=AN((t-x)+)+1AN(t)1τiN+ηi>t 2.7

Thus, the number of newly infected individuals that remain infected at time t can be written as

I1N(t)=I1N(t,t). 2.8

We also have the total number of individuals infected at time t that have been infected for a duration which is less than or equal to x:

IN(t,x)=I0N(t,x)+I1N(t,x),t0,x0.

Note that for each t, the support of the measure I0N(t,dx) is included in [0,t+x¯] and the support of the measure I1N(t,dx) is included in [0, t]. Thus

IN(t)=I0N(t,t+x¯)+I1N(t,t)=IN(t,),t0.

Here we occasionally use in the second component for convenience with the understanding that I0N(t,x)=I0N(t,t+x¯) for x>t+x¯ and I1N(t,x)=I1N(t,t) for x>t.

We also have for t0,

SN(t)=SN(0)-AN(t), 2.9
RN(t)=j=1IN(0)1ηj0t+i=1AN(t)1τiN+ηit. 2.10

We remark that the sample paths of IN(t,x) belong to the space DD, denoting D(R+;D(R+;R)), the D-valued D space, but not in the space D(R+2;R). We prove the weak convergence in the space DD where both D spaces are endowed with the Skorohod J1 topology. Note that the space D(R+2;R) is a strict subspace of DD, although they are equivalent in the continuous cases, that is, C(R+2;R)=CC. See more discussions on these spaces in [2, 3, 26, 27].

Remark 2.1

The SEIR model. Suppose that λi(t)=0 for t[0,ξi), where ξi<ηi, and denote I as the compartment of infected (not necessarily infectious) individuals. An individual who gets infected at time τiN is first exposed during the time interval [τiN,τiN+ζi), and then infectious during the time interval (τiN+ζi,τiN+ηi). One may state that the individual is infected during the time interval [τiN,τiN+ηi). At time τiN+ηi, he recovers. All what follows covers perfectly this situation. In other words, our model accomodates perfectly an exposed period before the infectious period, which is important for many infectious diseases, including the Covid-19. However, we distinguish only three compartments, S for susceptible, I for infected (either exposed or infectious), R for recovered.

In the sequel, the time interval [τiN,τiN+ηi) will be called the infectious period, although it might rather be the period during which the individual is infected (either exposed or infectious).

FLLN

Define the LLN-scaled processes X¯N=N-1XN for any processes XN. We make the following assumptions on the initial quantities.

Assumption 2.1

There exists a deterministic continuous nondecreasing function I¯(0,x) for x0 with I¯(0,0)=0 such that I¯N(0,·)I¯(0,·) in D in probability as N. Let I¯(0)=I¯(0,x¯). Then (I¯N(0),S¯N(0))(I¯(0),S¯(0))(0,1)2 in probability as N where S¯(0)=1-I¯(0)(0,1).

Remark 2.2

Recall that I¯N(0,·) describes the distribution of the initially infected individuals over the ages of infection. The assumption means that there is a corresponding limiting continuous distribution as the population size goes to infinity.

Suppose now that the r.v.’s {τj,0N}1jN are not ordered, but rather i.i.d., with a common distribution function G which we assume to be continuous. It then follows from the law of large numbers that Assumption 2.1 holds in this case.

We make the following assumption on the random function λ.

Assumption 2.2

Let λ(·) be a process having the same law of {λj0(·)}j and {λi(·)}i. Assume that there exists a constant λ such that for each 0<T<, supt[0,T]λ(t)λ almost surely. Assume that there exist an integer k, a random sequence 0=ζ0ζ1ζk and associated random functions λC(R+;[0,λ]), 1k, such that

λ(t)==1kλ(t)1[ζ-1,ζ)(t). 2.11

In addition, we assume that there exists a deterministic nondecreasing function φC(R+;R+) with φ(0)=0 such that |λ(t)-λ(s)|φ(t-s) almost surely for all t,s0 and for all 1. Let λ¯(t)=E[λi(t)]=E[λj0(t)] and v(t)=Var(λ(t))=E[(λ(t)-λ¯(t))2] for t0.

Remark 2.3

Recall that the basic reproduction number R0 is the mean number of susceptible individuals whom an infectious individual infects in a large population otherwise fully susceptible. In the present model, clearly

R0=0λ¯(t)dt.

Suppose that λi(t)=λ~(t)1t<ηi, where λ~(t) is a deterministic function. Then

R0=0λ~(t)Fc(t)dt.

In the standard SIR model with λ~(t)λ and E[η]=0Fc(t)dt, the formula above reduces to the well known R0=λE[η]. See, e.g., [5]. We obtain the same formula if the deterministic function λ~(t) is replaced by a process λi(t) independent of ηi, with mean λ~(t). More precisely, in that case the sequence (λi(t),ηi)i1 is assumed to be i.i.d., and for each i, λi and ηi are independent.

The proof of the following Theorem, which is the main result of this section, will be given in Sect. 5. For a function u(t,x)DD, we use the equivalent notations dxu(t,x) and ux(t,x) for the partial derivative w.r.t. x, while u(tdx) denotes the measure whose distribution function is xu(t,x), which coincides with ux(t,x)dx if that last map is differentiable. In particular, ux(t,0) indicates the partial derivative evaluated at x=0.

Theorem 2.1

Under Assumptions 2.1 and 2.2, as N,

(S¯N,I¯N,I¯N,R¯N)(S¯,I¯,I¯,R¯)in probability, locally uniformly intandx, 2.12

where the limits are the unique continuous solution to the following set of integral equations, for t,x0,

S¯(t)=1-I¯(0)-0tΥ¯(s)ds, 2.13
I¯(t)=0x¯λ¯(y+t)I¯(0,dy)+0tλ¯(t-s)Υ¯(s)ds, 2.14
I¯(t,x)=0(x-t)+Fc(t+y)Fc(y)I¯(0,dy)+(t-x)+tFc(t-s)Υ¯(s)ds, 2.15
R¯(t)=0x¯1-Fc(t+y)Fc(y)I¯(0,dy)+0tF(t-s)Υ¯(s)ds, 2.16

with

Υ¯(t)=S¯(t)I¯(t)=I¯x(t,0). 2.17

The function I¯(t,x) is nondecreasing in x for each t. As a consequence, I¯NI¯ in D in probability as N where

I¯(t)=I¯(t,t+x¯)=0x¯Fc(t+y)Fc(y)I¯(0,dy)+0tFc(t-s)Υ¯(s)ds,t0. 2.18

PDE Models

One can regard I¯(t,x) as the ‘distribution function’ of I¯(t)=I¯(t,t+x¯) over the ‘ages’ x[0,t+x¯) for each fixed t. If xI¯(t,x) is absolutely continuous, we denote by i¯(t,x)=I¯x(t,x) the density function of I¯(t,x) with respect to x. Note that S¯(t)=0 for t<0 and i¯(t,x)=0 both for t<0 and x<0.

The Case F Absolutely Continuous

In this subsection, we assume that F is absolutely continuous, F(dx)=f(x)dx, and we denote by μ(x) the hazard function of the r.v. η, i.e., μ(x):=f(x)/Fc(x) for x0. If the density function i¯(t,x) exists, we obtain the following PDE representation.

Proposition 3.1

Suppose that F is absolutely continuous, with the density f, and that I¯(0,x) is differentiable with respect to x, with the density function i¯(0,x). Then for t>0, the increasing function I¯(t,·) is absolutely continuous, and (tx) a.e. in (0,+)2,

i¯(t,x)t+i¯(t,x)x=-μ(x)i¯(t,x), 3.1

with the initial condition i¯(0,x)=I¯x(0,x) for x[0,x¯], and the boundary condition

i¯(t,0)=S¯(t)0t+x¯λ¯(x)Fc(x)Fc(x-t)i¯(t,x)dx, 3.2

with the convention that Fc=1 on R-, and that the integrand in (3.2) is zero when Fc(x)=0.

In addition,

S¯(t)=-i¯(t,0),andS¯(0)=1-I¯(0). 3.3

Moreover, the PDE (3.1) has a unique solution which is given as follows. For xt,

i¯(t,x)=Fc(x)Fc(x-t)i¯(0,x-t), 3.4

while for t>x,

i¯(t,x)=Fc(x)i¯(t-x,0), 3.5

and the boundary function is the unique solution of the integral equation

i¯(t,0)=S¯(0)-0ti¯(s,0)ds×0x¯λ¯(y+t)i¯(0,y)dy+0tλ¯(t-s)i¯(s,0)ds. 3.6

Remark 3.1

The PDE (3.1) can be considered as a linear equation, with a nonlinear boundary condition which is the integral Eq. (3.6).

It follows from (3.4) and (3.5) that Fc(x)=0 implies that i¯(t,x)=0. This is why we can impose that the integrand in the right hand side of (3.2) is zero whenever Fc(x)=0.

We remark that the PDE given in [19] resembles that given in (3.1), see Eqs. (28)–(29), see also Eq. (2.2) in [15]. In particular, the function μ(x) is interpreted as the recovery rate at infection age x. Equivalently, it is the hazard function of the infectious duration.

Remark 3.2

In a sense, what we do in the present paper can be interpreted as follows: we replace the two-dimensional system of equations with memory (2.13)–(2.14) (with, see (2.17), Υ¯(t) replaced by S¯(t)I¯(t)) by the infinite dimensional system of ODE-PDE (2.13)–(3.1)–(3.2) (with, see again (2.17), Υ¯(t) replaced by i¯(t,0)).

At the level of our population of size N, we have a two-dimensional non-Markov process (SN(t),IN(t)). For any t0, let i¯N(t) denote the measure whose distribution function is xI¯N(t,x). Theorem 2.1 implies that locally uniformly in t, i¯N(t) converges weakly to the measure which has the density i¯(t,x) w.r.t. Lebesque’s measure. i¯N(t) is a point measure which assigns the mass N-1 to any x which is the infection age of one of the individuals infected at time t. Clearly, from the knowledge of i¯N(t), we can deduce the values of both IN(0) and AN(t), hence of SN(0) and of SN(t) (see (2.9)). Note that the points of the measure i¯N(t) which are larger than t are the {τ~j,0N+t,1jIN(0)}, and those which are less than t are the {t-τiN,1iAN(t)}. Hence from (2.2), IN(t) is a function of both i¯N(t) and the λi’s. The same is true for ΥN(t). Conditionally upon the λi’s, the process i¯N(t) is a measure-valued Markov process, which evolves as follows. Each point x which belongs to it increases at speed 1, dies at rate μ(x), and new points are added at rate ΥN(t). i¯N(t) is determined by a sequence of at most N positive numbers; it can be considered as an element of k=1NRk. We have “Markovianized” the two-dimensional non-Markov process (SN(t),IN(t)), at the price of increasing dramatically the dimension.

Note that the pair composed of i¯N(t) and the collection {λj0,1jIN(0);λi,1iAN(t)} is a Markov process with values in k=1N(R×D)k. i¯N(t) evolves as above, and each new λi is a random element of D with the same law, independent of everything else.

We expect to write and study the equation for the measure-valued Markov process i¯N(t) in a future work.

Remark 3.3

Recall the special case in Remark 2.3 with λi(t)=λ~(t)1t<ηi, where λ~(t) is a deterministic function. Then λ¯(t)=λ~(t)Fc(t), and E[λ0(t)|τ~0N=y]=λ~(t+y)Fc(t+y)Fc(y). In that case, the boundary condition in (3.2) becomes

i¯(t,0)=S¯(t)0t+x¯λ~(x)i¯(t,x)dx

This is usually how the boundary condition is imposed in the literature of PDE epidemic models (see, e.g., [15, Eq. (2.5)], [22, Eq. (1.1)] and [12, Eq. (2)]). This expression has clearly a very intuitive interpretation. i¯(t,0) is the instantaneous rate for an individual to get infected at time t (resulting in a newly infectious individual with a zero age of infection), while the right hand side is the instantaneous infection rate by the existing infectious population at time t, which depends on all the infectious individuals with all ages of infection. This of course includes time t=0, which formulates a constraint on the initial condition {I¯(0,x)}0xx¯.

Proof

By the fact that F has a density, we see that the two partial derivatives of I¯ exist (tx) a.e. From (2.15), they satisfy

I¯t(t,x)=-1xtFc(x)Fc(x-t)I¯x(0,x-t)-0(x-t)+f(t+y)Fc(y)I¯x(0,y)dy+I¯x(t,0)-1t>xFc(x)I¯x(t-x,0)-(t-x)+tf(t-s)I¯x(s,0)ds, 3.7

and

I¯x(t,x)=1xtFc(x)Fc(x-t)I¯x(0,x-t)+1t>xFc(x)I¯x(t-x,0). 3.8

Thus, summing up (3.7) and (3.8), we obtain for t>0 and x>0,

I¯t(t,x)+I¯x(t,x)=-0(x-t)+f(t+y)Fc(y)I¯x(0,y)dy+I¯x(t,0)-(t-x)+tf(t-s)I¯x(s,0)ds. 3.9

Denote I¯x,t(t,x)=2I¯(t,x)xt=xI¯t(t,x) and I¯x,x(t,x)=2I¯(t,x)xx. By taking the derivative on both sides of (3.9) with respect to x (possibly in the distributional sense for each term on the left), we obtain for t>0 and x>0,

I¯x,t(t,x)+I¯x,x(t,x)=-1xtf(x)Fc(x-t)I¯x(0,x-t)-1t>xf(x)I¯x(t-x,0). 3.10

Since 2I¯(t,x)xt=2I¯(t,x)tx, we obtain the expression

i¯(t,x)t+i¯(t,x)x=-1xtf(x)Fc(x-t)i¯(0,x-t)-1t>xf(x)i¯(t-x,0). 3.11

As concerns the boundary condition, we note that, given (3.3), (3.4) and (3.5), (3.2) and (3.6) are equivalent. Hence we will establish (3.6), (3.3), (3.4) and (3.5).

For the boundary condition i¯(t,0), by (2.14) and (2.17), we have

i¯(t,0)=S¯(t)0x¯λ¯(y+t)i¯(0,y)dy+0tλ¯(t-s)i¯(s,0)ds,

where by (2.13),

S¯(t)=S¯(0)-0ti¯(s,0)ds.

Thus we obtain the expression in (3.6). We next prove that equation (3.6) has a unique non-negative solution. Observe that u(t)=i¯(t,0) is also a solution to

u(t)=0x¯λ¯(y+t)i¯(0,y)dy+0tλ¯(t-s)u(s)dsS¯(0)-0tu(s)ds+, 3.12

and any non-negative solution of (3.6) solves (3.12).

First, note that since for any t0, 0λ¯(t)λ,

00x¯λ¯(y+t)i¯(0,y)dyλI¯(0), 3.13

from which we conclude that 0tu(s)dsS¯(0). Indeed, if that were not the case, there would exist a time TS¯(0)<t such that 0TS¯(0)u(s)ds=S¯(0), hence 0tu(s)dsS¯(0) and from (3.12), we would have u(t)=0 for any tTS¯(0), so that indeed 0tu(s)dsS¯(0).

Under Assumption 2.2, using (3.13), if u1(t) and u2(t) are two nonnegative integrable solutions, then

|u1(t)-u2(t)|S¯(0)0tλ¯(t-s)|u1(s)-u2(s)|ds+λ(I¯(0)+S¯(0))0t|u1(s)-u2(s)|ds2λ0t|u1(s)-u2(s)|ds,

which, combined with Gronwall’s Lemma, implies that u1u2. Now existence is provided by the fact that the function i¯(t,0) is a non-negative solution of (3.12).

Note also that clearly, using a combination of an argument similar to that used for uniqueness, and of the classical estimate on Picard iterations for ODEs, one could establish that the sequence defined by u(0)(t)0 and for n0,

u(n+1)(t)=S¯(0)-0tu(n)(s)ds0x¯λ¯(y+t)i¯(0,y)dy+0tλ¯(t-s)u(n)(s)ds,

given i¯(0,·), is a Cauchy sequence in C(R+), hence existence.

We next derive the explicit solution expressions in (3.4) and (3.5). It follows from (3.11)Â that for xt, 0st,

i¯s(s,x-t+s)=-f(x-t+s)Fc(x-t)i¯(0,x-t),

while for t>x, 0sx,

i¯s(t-x+s,s)=-f(s)i¯(t-x,0).

Integrating the first identity from s=0 to s=t, we deduce that for xt,

i¯(t,x)=i¯(0,x-t)-i¯(0,x-t)Fc(x-t)0tf(x-t+s)ds=i¯(0,x-t)1-F(x)-F(x-t)Fc(x-t)=Fc(x)Fc(x-t)i¯(0,x-t),

so that for xt,

f(x)Fc(x-t)i¯(0,x-t)=f(x)Fc(x)i¯((t,x). 3.14

Now for t>x, we integrate the second identity from s=0 to s=x, and get

i¯(t,x)=i¯(t-x,0)-i¯(t-x,0)0xf(s)ds=Fc(x)i¯(t-x,0).

Hence for t>x,

f(x)i¯(t-x,0)=f(x)Fc(x)i¯(t,x). 3.15

Clearly, (3.4) is equivalent to (3.14), (3.5) is equivalent to (3.15), and (3.1) follows from (3.11), (3.14) and (3.15).

Corollary 3.1

The formula (2.14) for I¯(t) can be rewritten

I¯(t)=0t+x¯λ¯(y)Fc(y)Fc(y-t)I¯(t,dy), 3.16

where Fc(z)=1, for z0.

Proof

We first deduce from (2.15) that for t>x, xI¯(t,x) is differentiable, and I¯(t,dx)=Fc(x)Υ¯(t-x), and for fixed t, on [0,x¯], the function yI¯(t,t+y) is of finite total variation and satisfies I¯(t,t+dy)=Fc(t+y)Fc(y)I¯(0,dy). Inserting the resulting formulas for I¯(0,dy) and Υ¯ in the first and second integrals of the right hand side of (2.14), we obtain

I¯(t)=0x¯λ¯(t+y)I¯(0,dy)+0tλ¯(x)Fc(x)I¯(t,dx)=0x¯λ¯(t+y)Fc(y)Fc(t+y)I¯(t,t+dy)+0tλ¯(x)Fc(x)I¯(t,dx),

from which the result follows.

Remark 3.4

In the special case λi(t)=λ~(t)1t<ηi as discussed in Remark 3.3, (3.16) reduces to the very simple formula

I¯(t)=0t+x¯λ~(y)I¯(t,dy). 3.17

A similar formula holds if we replace the deterministic function λ~(t) by a copy λi(t) of a random function, which is independent of ηi, as discussed in Remark 2.3, and whose expectation is λ~(t). Then, we have

Υ¯(t)=S¯(t)I¯(t)=S¯(t)0t+x¯λ~(x)I¯(t,dx)=S¯(t)0t+x¯λ~(x)i¯(t,x)dx 3.18

Since i¯(t,0)=Υ¯(t), the results above can be stated using this expression of Υ¯.

In the special case of exponentially distributed infectious periods, i.e. μ(x)μ, we obtain the following well known results, see, e.g., [16, 22, 28].

Corollary 3.2

If the c.d.f. F(t)=1-e-μt, we have for t>0 and x>0,

i¯(t,x)t+i¯(t,x)x=-μi¯(t,x) 3.19

with the initial condition i¯(0,x) given for x[0,x¯] and the boundary condition for i¯(t,0) as given in (3.6).

Proof

In this case, the above proof simplifies. Indeed, we have for t0 and x0,

I¯(t,x)=1xte-μtI¯(0,x-t)+(t-x)+te-μ(t-s)Υ¯(s)ds.

By taking derivative with respect to x when t>0 and x>0, we obtain that equation (3.8) becomes

i¯(t,x)=1xti¯(0,x-t)e-μt+1x<te-μxI¯x(t-x,0).

Taking derivatives of this equation with respect to t and x, we obtain for t>0 and x>0,

i¯(t,x)t+i¯(t,x)x=-1xti¯(0,x-t)μe-μt-μe-μxI¯x(t-x,0)=-μi¯(t,x).

The boundary conditions follow in the same way as in the general model.

Remark 3.5

If the remaining infectious periods of the initially infectious individuals {ηj0,j=1,,IN(0)} are i.i.d. with c.d.f. F0 instead of depending on the infection age in (2.1), then we obtain the limits

I¯(t,x)=I¯(0,(x-t)+)F0c(t)+(t-x)+tFc(t-s)Υ¯(s)ds,R¯(t)=I¯(0)F0(t)+0tF(t-s)Υ¯(s)ds,

(noting that they are not continuous unless F0 is continuous), and assuming the density functions exist, we obtain the PDE:

i¯(t,x)t+i¯(t,x)x=-1x>tμ0(t)+1t>xμ(x)i¯(t,x),

where μ0(t)=f0(t)/F0c(t). As in the proof of Proposition 3.1, we obtain that the PDE (3.1) has a unique solution which is given as follows. For xt,

i¯(t,x)=F0c(t)i¯(0,x-t),

while for t>x,

i¯(t,x)=Fc(x)i¯(t-x,0),

and the boundary function is the unique solution of the integral equation

i¯(t,0)=S¯(0)-0ti¯(s,0)ds0x¯λ¯(y+t)i¯(0,y)dy+0tλ¯(t-s)i¯(s,0)ds.

The General Case

We now generalize the result of Proposition 3.1 to the case where the distribution F is not absolutely continuous. We denote below by ν the law of η, i.e. the measure whose distribution function is F. For reasons which will be explained in Remark 3.6 below, we shall in this subsection use the left continuous versions of F and Fc. In order to simplify notations, we define

G(t)=F(t-),Gc(t)=1-G(t)=Fc(t-).

Proposition 3.2

Suppose that I¯(0,x) is differentiable with respect to x, with the density function i¯(0,x). Then for t>0, the increasing function I¯(t,·) is absolutely continuous, and the following identity holds:

i¯(t,x)t+i¯(t,x)x=-i¯(t,x)Gc(x)ν(dx), 3.20

(i.e., the distribution which appears on the left hand side of (3.20) equals the measure which has the density -i¯(t,x)Gc(x) with respect to the measure ν) with the initial condition i¯(0,x)=I¯x(0,x) for x[0,x¯], and the boundary condition

i¯(t,0)=S¯(t)0t+x¯λ¯(x)Gc(x)Gc(x-t)i¯(t,x)dx, 3.21

with the convention that Gc=1 on R-, and that the integrand in (3.21) is zero whenever Gc(x)=0.

In addition,

S¯(t)=-i¯(t,0),andS¯(0)=1-I¯(0). 3.22

Moreover, the PDE (3.20) has a unique solution which is given as follows. For xt,

i¯(t,x)=Gc(x)Gc(x-t)i¯(0,x-t), 3.23

while for t>x,

i¯(t,x)=Gc(x)i¯(t-x,0), 3.24

and the boundary function is the unique solution of the integral equation

i¯(t,0)=S¯(0)-0ti¯(s,0)ds0x¯λ¯(y+t)i¯(0,y)dy+0tλ¯(t-s)i¯(s,0)ds. 3.25

Remark 3.6

The product i¯(t,x)Gc(x)ν(dx) can also be rewritten as

i¯(t,x)×ν(dx)Gc(x),

where the second factor can be thought of as the “hazard measure”, i.e., the generalization of the hazard function, of the r.v. η. The reason why we want to have Gc(x) in the denominator, and not Fc(x) is the following. If the support of ν is [0,xmax], and ν({xmax})>0, then Fc(xmax)=0, while Gc(xmax)>0 and we need a positive denominator at the point xmax, since ν({xmax})>0.

For consistency, in the present subsection we always choose the left continuous version G (resp. Gc) of F (resp. Fc). Of course, in the case where F is absolutely continuous this makes no difference.

Remark 3.7

Remark 3.2 can be extended to the present case of a general distribution function F, replacing the infinite dimensional system of ODE-PDE (2.13)–(3.1)–(3.2) by (2.13)–(3.20)–(3.21).

Proof

We first rewrite Eq. (2.15) as

I¯(t,x)=0(x-t)+I¯x(0,y)Gc(y)Gc(t+y)dy+(t-x)+tI¯x(s,0)Gc(t-s)ds.

Differentiating I¯(t,x) in x can be done exactly as in the proof of Proposition 3.1. Concerning the differentiation in t, the differentiation with respect to t appearing in the integrands Gc(t+y) and Gc(t-s) is now a bit more delicate: those functions have not been assumed to be differentiable. Their derivatives in the distributional sense is a measure, whose bracket with a measurable bounded function makes sense, so that

ddtabI¯x(0,y)Gc(y)Gc(t+y)dy=abI¯x(0,y)Gc(y)ν(t+dy)=a+tb+tI¯x(0,z-t)Gc(z-t)ν(dz),ddtabGc(t-s)I¯x(s,0)ds=abI¯x(s,0)ν(t-ds)=t-bt-aI¯x(t-r,0)ν(dr).

As a consequence, the above modification in the proof of Proposition 3.1 yields

I¯t(t,x)+I¯x(t,x)=I¯x(t,0)-txtI¯x(0,z-t)Gc(z-t)ν(dz)-0xtI¯x(t-r,0)ν(dr).

Differentiating with respect to x finally yields

i¯(t,x)t+i¯(t,x)x=-1xti¯(0,x-t)Gc(x-t)ν(dx)-1x<ti¯(t-x,0)ν(dx).

We thus deduce that for xt, 0st,

i¯s(s,x-t+s)=-i¯(0,x-t)Gc(x-t)ν(x-t+ds),

while for t>x, 0sx,

i¯s(t-x+s,s)=-i¯(t-x,0)ν(ds).

Let us integrate the first identity on the interval [0, t). We get

i¯(t,x)=i¯(0,x-t)1-[0,t)ν(x-t+ds)Gc(x-t)=i¯(0,x-t)1-G(x)-G(x-t)Gc(x-t)=Gc(x)Gc(x-t)i¯(0,x-t).

We conclude that for xt,

i¯(0,x-t)Gc(x-t)ν(dx)=i¯(t,x)Gc(x)ν(dx).

We finally consider the case t>x, and integrate the second identity on the interval [0, x), yielding:

i¯(t,x)=i¯(t-x,0)1-[0,x)ν(ds)=Gc(x)i¯(t-x,0),

so that, for t>x,

i¯(t-x,0)ν(dx)=i¯(t,x)Gc(x)ν(dx),

and we have established (3.23), (3.24), as well as (3.20). The rest of the proof is the same as that of Proposition 3.1.

The case of a deterministic duration η is a particular case of the last Proposition.

Corollary 3.3

Suppose that the infectious periods are deterministic and equal to ti, i.e., F(t)=1tti, G(t)=1t>ti. Then we have

i¯(t,x)t+i¯(t,x)x=-δti(x)i¯(t,x), 3.26

with δti(x) being the Dirac measure at ti, with the initial condition i¯(0,x)=xI¯(0,x) for x[0,ti], and the boundary condition

i¯(t,0)=S¯(t)0(t+ti)tiλ¯(x)i¯(t,x)dx, 3.27

Note also that the boundary function i¯(t,0) solves the following Volterra equation: if 0<t<ti,

i¯(t,0)=S¯(0)-0ti¯(s,0)ds×ttiλ¯(y)i¯(0,y-t)dy+0tλ¯(t-s)i¯(s,0)ds, 3.28

and if tti,

i¯(t,0)=S¯(0)-0ti¯(s,0)ds0tiλ¯(y)i¯(t-y,0)dy, 3.29

The PDE (3.26) has a unique solution i¯(t,x), which is given as follows. i¯(t,x)=0 if xti. For tx<ti,

i¯(t,x)=i¯(0,x-t), 3.30

while for x<tti,

i¯(t,x)=i¯(t-x,0). 3.31

Remark 3.8

The total fraction of the population infected during the epidemic is given by

Φ=0i¯(t,0)dt

where i¯(t,0) is the solution to (3.6). We also refer the reader to equation (12) in Kaplan [17], based on his constructed “Scratch" model.

On the SIS Model with Infection-Age Dependent Infectivity

In the SIS model, the infectious individuals become susceptible once they recover. Since SN(t)+IN(t)=N for each t0 with a population size N, the epidemic dynamics is determined by the process IN(t) alone, and we have the same representations of the processes I0N(t,x) and I1N(t,x) in (2.5) and (2.7), respectively, while in the representations of AN in (2.4) and ΥN in (2.3), the process SN(t) is replaced by SN(t)=N-IN(t). The aggregate infectivity process IN(t) is still given by (2.2). The two processes (IN,IN) determine the dynamics of the SIS epidemic model. Under Assumptions 2.1 and 2.2,

(I¯N,I¯N)(I¯,I¯)in probability, locally uniformly intandx,asN, 4.1

where

I¯(t)=0x¯λ¯(y+t)I¯(0,dy)+0tλ¯(t-s)(1-I¯(s,))I¯(s)ds, 4.2
I¯(t,x)=0(x-t)+Fc(t+y)Fc(y)I¯(0,dy)+(t-x)+tFc(t-s)(1-I¯(s,))I¯(s)ds, 4.3

for t,x0. If I(0,x) is differentiable and F is absolutely continuous, then the density function i¯(t,x)=I¯(t,x)x exists and satisfies again (3.1). The same calculations as in the case of the SIR model lead to (3.4), (3.5) and (3.2). However, the formula for S¯(t) is different in the case of the SIS model, that is, (3.3) does not hold. Instead, we have

S¯(t)=1-I¯(t)=1-0x¯Fc(t+y)Fc(y)i¯(0,y)dy-0tFc(t-s)i¯(s,0)ds. 4.4

Thus, the Volterra equation on the boundary reads

i¯(t,0)=0x¯λ¯(t+y)i¯(0,y)dy+0tλ¯(t-s)i¯(s,0)ds×1-0x¯Fc(t+y)Fc(y)i¯(0,y)dy-0tFc(t-s)i¯(s,0)ds, 4.5

whose form is similar to the one for the SIR model.

It is also clear that if the c.d.f. F(t)=1-e-βt, we have the same PDE for i¯(t,x) as given in (3.19) with μ(x)=β and the boundary condition:

i¯(t,0)=0x¯λ¯(t+y)e-βyi¯(0,y)dy+0tλ¯(t-s)e-β(t-s)i¯(s,0)ds×1-0x¯e-βti¯(0,y)dy-0te-β(t-s)i¯(s,0)ds.

If the c.d.f. F of the infectious period is not absolutely continuous, but I(0,x) is differentiable, then we have essentially the same result as in Proposition 3.2, except that (3.22) is replaced by (4.4), and (3.25) by (4.5).

Recall that the standard SIS model has a nontrivial equilibrium point I¯=1-β/λ if β<λ, where λ is the infection rate (the bar over λ is dropped for convenience), and 1/β is the mean of the infectious periods. See Sect. 4.3 in [25] for the account of the SIS model with general infectious periods. Here we consider the model in the generality of infection-age dependent infectivity. Note that we provide the explicit expressions for the equilibria below assuming they exist. We do not prove the existence of the limit of I¯(t,x) as t, which we leave as future work.

Proposition 4.1

Suppose that limI¯(t,x)I¯(x) exists as t and I¯=I¯(). If R0=0λ¯(y)dy1, I¯=0 (the disease free equilibrium). In the complementary case, R0=0λ¯(y)dy>1, if I¯(0,x¯)>0,

I¯=1-0λ¯(y)dy-1=1-1R0. 4.6

The density function i¯(t,x) has an equilibrium i¯(x) in the age of infection x, given by

i¯(x)=dI¯(x)dx=I¯βFc(x), 4.7

where β-1=0Fc(t)dt(0,) is the expectation of the duration of the infectious period. If F has a density f, then the equilibrium density i¯(x) satisfies

di¯(x)dx=-I¯βf(x),i¯(0)=I¯β.

Proof

The fact that I¯=0 if R01 and >0 if R0>1 follows from branching process arguments, and the fact that the start of the epidemic can be approximated by a branching process, see e.g. Sect. 1.3 in [5]. Assume that the equilibrium I¯(x):=I¯(,x) exists. We deduce from (4.3), combined with (3.16), that I¯(x) must satisfy

I¯(x)=(1-I¯())0xFc(u)du0λ¯(y)Fc(y)I¯(dy)=(1-I¯)β-1Fe(x)0λ¯(y)Fc(y)I¯(dy),

where Fe(x)=β0xFc(s)ds, the equilibrium (stationary excess) distribution. Letting x in this formula, we deduce

I¯=(1-I¯)β-10λ¯(y)Fc(y)I¯(dy). 4.8

Combining the last two equations, we obtain

I¯(x)=I¯Fe(x). 4.9

Plugging this formula in the previous identity, we deduce that

I¯=(1-I¯)I¯0λ¯(y)dy.

Then the formula (4.6) can be directly deduced from this equation. The formula (4.7) follows by taking the derivative with respect to x in (4.9).

Remark 4.1

If the distribution F is exponential, that is, F(x)=1-e-βx, then we obtain

I¯(x)=I¯(1-e-βx),i¯(x)=I¯βe-βx,anddi¯(x)dx=-I¯β2e-βx=-βi¯(x),

where I¯ is given in (4.6).

Remark 4.2

Suppose that λi(t)=λ(t)1t<ηi, where λ(t) is a deterministic function, as in Remark 3.4. Then λ¯(t)=λ(t)Fc(t). If λ(t)λ is a constant and F has mean β-1, then I¯ in (4.6)

I¯=1-λ0Fc(y)dy-1=1-β/λ=1-1R0, 4.10

which reduces to the well known result for the standard SIS model with constant rates, assuming β<λ.

Proof of the FLLN

In this section, we prove Theorem 2.1. We will need the following theorem. A similar pre-tightness criterion can be found in Theorem 3.5.1 in Chapter 6 of [21], which extends that in the Corollary on page 83 of [4] to the space C([0,1]k,R). Those proofs can be easily extended to the space DD. For the convenience of the reader, we give a proof of the following result in Sect. 6 below.

Theorem 5.1

Let {XN:N1} be a sequence of random elements in DD. If the following two conditions are satisfied: for any T,S>0,

  • (i)

    for any ϵ>0, supt[0,T]sups[0,S]P(|XN(t,s)|>ϵ)0 as N, and

  • (ii)
    for any ϵ>0, as δ0,
    lim supNsupt[0,T]1δP(supu[0,δ]sups[0,S]|XN(t+u,s)-XN(t,s)|>ϵ)0,lim supNsups[0,S]1δP(supv[0,δ]supt[0,T]|XN(t,s+v)-XN(t,s)|>ϵ)0,

then XN(t,s)0 in probability, locally uniformly in t and s, as N.

We shall also use repeatedly the following Lemma.

Lemma 5.1

Let fD(R+) and {gN}N1 be a sequence of elements of D(R+) which is such that gNg locally uniformly, where gC(R+). Then for any T>0,

[0,T]f(t)gN(dt)[0,T]f(t)g(dt).

Proof

The assumption implies that the sequence of measures gN(dt) converges weakly, as N, towards the measure g(dt). Since moreover f is bounded, and the set of discontinuities of f is of g(dt) measure 0, this is essentially a minor improvement of the Portmanteau theorem, see [4].

Convergence of I0N(t,x)

We first treat the process I0N(t,x) in (2.5).

Lemma 5.2

Under Assumption 2.1,

I¯0N(t,x)I¯0(t,x)inDDasN, 5.1

in probability, where the limit I¯0(t,x) is given by

I¯0(t,x):=0(x-t)+Fc(t+y)Fc(y)I¯(0,dy),t,x0. 5.2

Proof

Recall that

I¯0N(t,x)=N-1j=1IN(0)1ηj0>t1τ~j,0N(x-t)+=N-1j=1IN(0,(x-t)+)1ηj0>t.

Note that the pair of variables (τ~j,0N,ηj0) satisfies (2.1), and IN(0,(x-t)+)=max{j1:τ~j,0N(x-t)+}. Let

I~0N(t,x)=N-1j=1IN(0,(x-t)+)Fc(t+τ~j,0N)Fc(τ~j,0N)=0(x-t)+Fc(t+y)Fc(y)I¯N(0,dy). 5.3

We will first show that I~0N(t,x)I¯0(t,x) (this will be step 1 of the proof), and then that I¯0N(t,x)-I~0N(t,x)0 (this will be step 2 of the proof), both in probability, locally uniformly in t and x, as N.

Step 1 We show that, as N,

I~0N(t,x)I¯0(t,x)in probability, locally uniformly intandx. 5.4

From Lemma 5.1, Assumption 2.1 and the continuous mapping theorem, we deduce that for any t,x0, I~0N(t,x)I¯0(t,x) in probability, as N. It thus remains to show that the sequence {XN:=I~0N-I¯0,N1} satisfies condition (ii) in Theorem 5.1. In fact, it is easily seen that it is sufficient to verify condition (ii) with XN=I~0N. Indeed, both

sup0uδsup0xx¯|I¯0(t+u,x)-I¯0(t,x)|andsup0vδsup0tT|I¯0(t,x+v)-I¯0(t,x)|

tend to 0, as δ0, which is an easy consequence of the computations which follow. Let us now consider XN=I~0N. We have

I~0N(t+u,x)-I~0N(t,x)=0(x-t-u)+Fc(t+u+y)Fc(y)I¯N(0,dy)-0(x-t)+Fc(t+y)Fc(y)I¯N(0,dy)=0(x-t-u)+Fc(t+u+y)-Fc(t+y)Fc(y)I¯N(0,dy)-(x-t-u)+(x-t)+Fc(t+y)Fc(y)I¯N(0,dy)

which gives

|I~0N(t+u,x)-I~0N(t,x)|0(x-t-u)+Fc(t+y)-Fc(t+u+y)Fc(y)I¯N(0,dy)+(x-t-u)+(x-t)+Fc(t+y)Fc(y)I¯N(0,dy).

Consequently,

sup0uδ,0xx¯|I~0N(t+u,x)-I~0N(t,x)|0(x¯-t)+Fc(t+y)-Fc(t+δ+y)Fc(y)I¯N(0,dy)+sup0xx¯(x-t-δ)+(x-t)+Fc(t+y)Fc(y)I¯N(0,dy).

The limit in probability of the first term on the right of the last inequality equals

0(x¯-t)+Fc(t+y)-Fc(t+δ+y)Fc(y)I¯(0,dy),

which tends to 0 as δ0, since Fc is continuous on the right and the integrand is between 0 and 1. The second term on the right of the above inequality is nonnegative and upper bounded by

sup0xx¯I¯N(0,(x-t)+)-I¯N(0,(x-t-δ)+),

which converges in probability towards

sup0xx¯I¯(0,(x-t)+)-I¯(0,(x-t-δ)+),

and this last expression tends to 0 as δ0. Combining the above arguments, we deduce that for ϵ>0, if δ>0 is small enough,

lim supNPsup0uδ,0xx¯|I~0N(t+u,x)-I~0N(t,x)|>ϵ=0.

We next consider

I~0N(t,x+v)-I~0N(t,x)=(x-t)+(x+v-t)+Fc(t+y)Fc(y)I¯N(0,dy)I¯N(0,(x+v-t)+)-IN(0,(x-t)+).

Hence,

sup0vδ,0tT|I~0N(t,x+v)-I~0N(t,x)|=sup0tTI¯N(0,(x+δ-t)+)-IN(0,(x-t)+).

The term on the right of the last inequality converges in probability as N, towards

sup0tTI¯(0,(x+δ-t)+)-I(0,(x-t)+),

which tends to 0 as δ tends to 0. Again we easily deduce from these computations that for any ϵ>0, if δ>0 is small enough,

lim supNPsup0vδ,0tT|I~0N(t,x+v)-I~0N(t,x)|>ϵ=0.

We have established (5.4).

Step 2 We finally show that VN(t,x):=I¯0N(t,x)-I~0N(t,x) satisfies the two conditions of Theorem 5.1. We have

VN(t,x)=N-1j=1IN(0,(x-t)+)1ηj0>t-Fc(t+τ~j,0N)Fc(τ~j,0N).

We first check condition (i) from Theorem 5.1. We have

E[VN(t,x)2]=E[N-2j=1IN(0,(x-t)+)1ηj0>t-Fc(t+τ~j,0N)Fc(τ~j,0N)2]+E[N-2j,j=1,jjIN(0,(x-t)+)1ηj0>t-Fc(t+τ~j,0N)Fc(τ~j,0N)1ηj0>t-Fc(t+τ~j,0N)Fc(τ~j,0N)]=N-1E[0(x-t)+Fc(t+s)Fc(s)(1-Fc(t+s)Fc(s))I¯N(0,ds)]

where the second term in the first equality is equal to zero by the independence of ηj0 and ηj0 given the times τ~j,0N and τ~j,0N and by using a conditioning argument. This implies that as N,

supt0supx0E[VN(t,x)2]0,

and thus condition (i) in Theorem 5.1 holds.

We next show condition (ii) from Theorem 5.1, that is, for any ϵ>0, as δ0,

lim supNsupt[0,T]1δPsupu[0,δ]supx[0,T]|VN(t+u,x)-VN(t,x)|>ϵ0, 5.5

and

lim supNsupx[0,T]1δPsupv[0,δ]supt[0,T]|VN(t,x+v)-VN(t,x)|>ϵ0. 5.6

We first prove (5.5). We have

|VN(t+u,x)-VN(t,x)|=|N-1j=1IN(0,(x-t-u)+)(1ηj0>t+u-Fc(t+u+τ~j,0N)Fc(τ~j,0N))-N-1j=1IN(0,(x-t)+)(1ηj0>t-Fc(t+τ~j,0N)Fc(τ~j,0N))||N-1j=1IN(0,(x-t-u)+)(1t<ηj0t+u-Fc(t+τ~j,0N)-Fc(t+u+τ~j,0N)Fc(τ~j,0N))|+|N-1j=IN(0,(x-t-u)+)+1IN(0,(x-t)+)(1ηj0>t-Fc(t+τ~j,0N)Fc(τ~j,0N))|N-1j=1IN(0,(x-t-u)+)1t<ηj0t+u+0(x-t-u)+Fc(t+s)-Fc(t+u+s)Fc(s)I¯N(0,ds)+|I¯N(0,(x-t)+)-I¯N(0,(x-t-u)+)|. 5.7

For the first term,

P(supu[0,δ]supx[0,T]N-1j=1IN(0,(x-t-u)+)1t<ηj0t+u>ϵ/3)P(N-1j=1IN(0,(T-t)+)1t<ηj0t+δ>ϵ/3)P(N-1j=1IN(0,(T-t)+)[1t<ηj0t+δ-Fc(t+τ~j,0N)-Fc(t+δ+τ~j,0N)Fc(τ~j,0N)]>ϵ/6)+P(0(T-t)+Fc(t+s)-Fc(t+δ+s)Fc(s)I¯N(0,ds)>ϵ/6) 5.8

By the conditional independence of the ηj0’s, the first term on the right of (5.8) is bounded by

36ϵ2N-1E0(T-t)+Fc(t+s)-Fc(t+δ+s)Fc(s)×1-Fc(t+s)-Fc(t+δ+s)Fc(s)I¯N(0,ds)36ϵ2N-1E0(T-t)+Fc(t+s)-Fc(t+δ+s)Fc(s)I¯N(0,ds),

which converges to zero as N. Since by Assumption 2.1I¯(0,·) is continuous, thanks to Lemma 5.1, lim supN of the second term is upper bounded by

1{0(T-t)+Fc(t+s)-Fc(t+δ+s)Fc(s)I¯(0,ds)ϵ/6},

which is zero for δ>0 small enough (clearly uniformly over t[0,T]).

The second term on the right of (5.7) is treated exactly as the last term we have just analyzed. Finally for the third term, we note that

Psupu[0,δ]supx[0,T]|I¯N(0,(x-t)+)-I¯N(0,(x-t-u)+)|>ϵ/3=Psupx[0,T]|I¯N(0,(x-t)+)-I¯N(0,(x-t-δ)+)|>ϵ/3.

Thanks to Assumption 2.1, the lim supN of this probability is upper bounded by

1supx[0,T]|I¯(0,(x-t)+)-I¯(0,(x-t-δ)+)|ϵ/3

which is zero for δ>0 small enough, since I¯(0,·) is continuous. The uniformity over t[0,T] is obvious. Thus we have shown (5.5).

We next prove (5.6). Observe that

VN(t,x+v)-VN(t,x)=N-1j=IN(0,(x-t)+)+1IN(0,(x+v-t)+)1ηj0>t-Fc(t+τ~j,0N)Fc(τ~j,0N)

from which we obtain

Psupv[0,δ]supt[0,T]|VN(t,x+v)-VN(t,x)|>ϵPsupv[0,δ]supt[0,T]|I¯N(0,(x+v-t)+)-I¯N(0,(x-t)+)|>ϵPsupt[0,T]|I¯N(0,(x+δ-t)+)-I¯N(0,(x-t)+)|>ϵ.

Then following the same argument as for the second term on the right of (5.7), we can conclude (5.6).

Convergence of I¯1N

We first write the process AN as

AN(t)=MAN(t)+ΛN(t), 5.9

where

ΛN(t):=0tΥN(s)ds, 5.10

and

MAN(t)=0t01uΥN(s-)Q¯(ds,du), 5.11

where Q¯(ds,du)=Q(ds,du)-dsdu is the compensated PRM.

Lemma 5.3

Under Assumption 2.2, the process {MAN(t):t0} is a square-integrable martingale with respect to the filtration FAN={FAN(t):t0} where

FAN(t):=σ{IN(0),τ~jN:j=1,,IN(0)}σ{λj0(·)j1,λi(·)i1}σ{0t01uΥN(s-)Q(ds,du):0tt}.

The quadratic variation of MAN(t) is given by

MAN(t)=ΛN(t),t0. 5.12

Proof

It is clear that MAN(t)FAN(t), and E[|MAN(t)|]2E[ΛN(t)]2λNt< for each t0, under Assumption 2.2. It suffices to verify the martingale property: for t2>t10,

E[MAN(t2)-MAN(t1)|FAN(t1)]=0

which can be checked using the above definition of the filtration. In addition, E[(MAN(t))2]=E[ΛN(t)]λNt< for each t0. The rest is standard.

Recall that (A¯N,S¯N,Υ¯N):=N-1(AN,SN,ΥN).

Lemma 5.4

Under Assumptions 2.1 and 2.2, the sequence of processes {(A¯N,S¯N):NN} is tight in D2. The limit of each convergence subsequence of {A¯N}, denoted by A¯, satisfies

A¯=limNA¯N=limN0·Υ¯N(u)du, 5.13

and

0stΥ¯N(u)duλ(t-s),w.p.1for0st. 5.14

Proof

It is clear that under Assumption 2.2, if Λ¯N(t):=0tΥ¯N(u)du, Λ¯N(0)=0 and

0Λ¯N(t)-Λ¯N(s)λ(t-s),w.p.1for0st. 5.15

Since

M¯ANtN-1λt,

it follows from Doob’s inequality that M¯AN(t) tends to 0 in probability, locally uniformly in t. The tightness of {A¯N:NN} in D follows. Since S¯N=S¯N(0)-A¯N and S¯N(0)S¯(0) from Assumption 2.1, we obtain the tightness of {S¯N:NN} in D, and thus the claim of the lemma.

In the following of this section, we consider a convergent subsequence of A¯N.

Recall that

I¯1N(t,x)=N-1i=AN((t-x)+)AN(t)1τiN+ηi>t,t,x0.

Lemma 5.5

Under Assumptions 2.1 and 2.2, along a subsequence of A¯N which converges weakly to A¯,

I¯1N(t,x)I¯1(t,x)inDDasN, 5.16

where the limit I¯1(t,x) is given by

I¯1(t,x):=(t-x)+tFc(t-s)dA¯(s),t,x0. 5.17

Proof

Let

I˘1N(t,x):=N-1i=AN((t-x)+)AN(t)Fc(t-τiN),t,x0.

We can write (from now on, ab stands for (a,b])

I˘1N(t,x)=(t-x)+tFc(t-s)dA¯N(s). 5.18

Then from Lemma 5.1, we deduce that for any t,x0,

I˘1N(t,x)I¯1(t,x)asN. 5.19

We will next show that for any ϵ>0, there exists δ>0 such that the following holds for any (tx):

lim supNPsupttt+δ,xxx+δI˘1N(t,x)-I˘1N(t,x)>ϵ=0, 5.20

It is not hard to deduce from (5.19) and (5.20), by a two-dimensional extension of the argument of the Corollary on page 83 of [4], that as N, I˘1N(t,x)I¯1(t,x) locally uniformly in t and x. Whenever ttt+δ and xxx+δ, we have

|I˘1N(t,x)-I˘1N(t,x)|(t-x)+t[Fc(t-s)-Fc(t-s)]dA¯N(s)+2sup0t2-t12δ[A¯N(t2)-A¯N(t1)].

Since A¯N(t)0tΥ¯(s)ds locally uniformly in t, and Υ¯(s)λ, the limit in law of the right hand side of the last inequality is bounded by

λ(t-x)+tsupttt+δ[Fc(t-s)-Fc(t-s)]ds+4λδ,

which is less than ϵ for δ>0 small enough. Hence, (5.20) follows.

Let now

YN(t,x):=I¯1N(t,x)-I˘1N(t,x)=N-1i=AN((t-x)+)AN(t)(1τiN+ηi>t-Fc(t-τiN)),t,x0.

To prove (5.16), it remains to show that, as N,

YN0inDDin probability. 5.21

We apply Theorem 5.1. By Markov’s inequality and the decomposition of AN(t) in (5.9) with E[MAN(t)]=0, we obtain

PYN(t,x)>ϵ1ϵ2EYN(t,x)2=1ϵ2NE(t-x)+tF(t-s)Fc(t-s)dA¯N(s)=1ϵ2NE(t-x)+tF(t-s)Fc(t-s)Υ¯N(s)ds1ϵ2Nλ(t-x)+tF(t-s)Fc(t-s)dssupt[0,T],x[0,T]PYN(t,x)>ϵ0asN.

The result then follows from the next two lemmas.

Lemma 5.6

Under the assumptions of Lemma 5.5, for ϵ>0, as δ0,

lim supNsupt[0,T]1δP(supu[0,δ]supx[0,T]|YN(t+u,x)-YN(t,x)|>ϵ)0, 5.22

Proof

We have

|YN(t+u,x)-YN(t,x)|=|N-1i=AN((t+u-x)+)AN(t+u)(1τiN+ηi>t+u-Fc(t+u-τiN))-N-1i=AN((t-x)+)AN(t)(1τiN+ηi>t-Fc(t-τiN))|=|N-1i=AN((t-x)+)AN(t+u)[(1τiN+ηi>t+u-Fc(t+u-τiN))-(1τiN+ηi>t-Fc(t-τiN))]-N-1i=AN((t-x)+)AN(t+u-x)+-1(1τiN+ηi>t+u-Fc(t+u-τiN))+N-1i=AN(t)+1AN(t+u)(1τiN+ηi>t-Fc(t-τiN))|N-1i=AN((t-x)+)AN(t+u)[1t<τiN+ηit+u+(Fc(t-τiN)-Fc(t+u-τiN))]+|N-1i=AN((t-x)+)AN(t+u-x)+-1(1τiN+ηi>t+u-Fc(t+u-τiN))|+|N-1i=AN(t)+1AN(t+u)(1τiN+ηi>t-Fc(t-τiN))|N-1i=AN((t-x)+)AN(t+u)1t<τiN+ηit+u+N-1i=AN((t-x)+)AN(t+u)(Fc(t-τiN)-Fc(t+u-τiN))+(A¯N((t+u-x)+)-A¯N((t-x)+))+(A¯N(t+u)-A¯N(t)).

Then we obtain

Psupu[0,δ]supx[0,T]|YN(t+u,x)-YN(t,x)|>ϵPN-1i=AN((t-T)+)AN(t+δ)1t<τiN+ηit+δ>ϵ/3+PN-1i=AN((t-T)+)AN(t+δ)(Fc(t-τiN)-Fc(t+δ-τiN))>ϵ/3+2Psup0sT|A¯N(s+δ)-A¯N(s)|>ϵ/6. 5.23

Let Q˘(ds,dr,dz) denote a PRM on R+3 with mean measure ν(ds,dr,dz)=dsdrF(dz) and Q~ denote the associated compensated PRM. By the Markov inequality, we obtain the first term is bounded by 9ϵ-2 times

EN-1i=AN((t-T)+)AN(t+δ)1t<τiN+ηit+δ2=EN-1(t-T)+t+δ0t-st+δ-s1rΥN(s-)Q˘(ds,dr,dz)22EN-1(t-T)+t+δ0t-st+δ-s1rNΥ¯N(s-)Q~(ds,dr,dz)2+2E(t-T)+t+δ(F(t+δ-s)-F(t-s))Υ¯N(s)ds2=2N-1E(t-T)+t+δ(F(t+δ-s)-F(t-s))Υ¯N(s)ds+2E(t-T)+t+δ(F(t+δ-s)-F(t-s))Υ¯N(s)ds22λN-1(t-T)+t+δ(F(t+δ-s)-F(t-s))ds+2λ(t-T)+t+δ(F(t+δ-s)-F(t-s))ds2,

where the last inequality follows from (5.14). The first term converges to zero as N, and we note that

(t-T)+t+δ(F(t+δ-s)-F(t-s))ds=t-(t-T)+t-(t-T)++δF(r)dr-0δF(r)drδ,

since F(r)1. Hence

1δλ(t-T)+t+δ(F(t+δ-s)-F(t-s))ds2λδ0,asδ0. 5.24

For the second term in (5.23), we have

E(t-T)+t+δ(Fc(t-s)-Fc(t+δ-s))dA¯N(s)22E(t-T)+t+δ(Fc(t-s)-Fc(t+δ-s))dM¯AN(s)2+2E(t-T)+t+δ(Fc(t-s)-Fc(t+δ-s))Υ¯N(s)ds2,

where the first term converges to zero as N by the convergence M¯AN(t)0 in probability, locally uniformly in t, while the second term is bounded as in (5.24).

For the last term in (5.23), we use the martingale decomposition of A¯N and the bound for Υ¯N in (5.14), and obtain

sup0tT|A¯N(t+δ)-A¯N(t)|2sup0tT+δ|M¯AN(t)|+λδ, 5.25

which, since M¯AN(t)0 locally uniformly in t, implies that, provided δ<ϵ/λ,

lim supNPsup0tT|A¯N(t+δ)-A¯N(t)|ϵ=0.

Thus we have shown that (5.22) holds.

Lemma 5.7

Under the assumptions of Lemma 5.5, for ϵ>0, as δ0,

lim supNsupx[0,T]1δP(supv[0,δ]supt[0,T]|YN(t,x+v)-YN(t,x)|>ϵ)0. 5.26

Proof

Observe that

YN(t,x+v)-YN(t,x)=N-1i=AN((t-x-v)+)AN((t-x)+)(1τiN+ηi>t-Fc(t-τiN)),

from which we obtain

P(supv[0,δ]supt[0,T]|YN(t,x+v)-YN(t,x)|>ϵ)P(supv[0,δ]supt[0,T]|A¯N((t-x)+)-A¯N((t-x-v)+)|>ϵ)P(supt[0,T]|A¯N((t-x)+)-A¯N((t-x-δ)+)|>ϵ).

Then the claim follows from the same argument as the one used to treat the last term in (5.23) in the end of the proof of the previous lemma.

Convergence of the Aggregate Infectivity Process

Recall IN in (2.2), and let I¯N:=N-1IN. Define

I~N(t):=N-1j=1IN(0)λ¯(τ~j,0N+t)+N-1i=1AN(t)λ¯(t-τiN),t0. 5.27

Lemma 5.8

Under Assumptions 2.1 and 2.2, along a convergent subsequence of A¯N which converges weakly to A¯, we have in probability,

I¯N-I~N0inDasN.

Proof

We write

I¯N(t)-I~N(t)=Ξ¯0N(t)+Ξ¯1N(t),

where

Ξ¯0N(t)=N-1j=1IN(0)(λj0(τ~j,0N+t)-λ¯(τ~j,0N+t)),Ξ¯1N(t)=N-1i=1AN(t)(λi(t-τiN)-λ¯(t-τiN)).

We first consider Ξ¯0N(t). For each fixed t, by conditioning on σ{IN(0,y):0yx¯}=σ{τ~j,0N,j=1,,IN(0)}, we obtain

E[(Ξ¯0N(t))2]=N-1E[0x¯v(y+t)dI¯N(0,y)]0asN.

We then have for t,u>0,

|Ξ¯0N(t+u)-Ξ¯0N(t)|N-1j=1IN(0)|λj0(τ~j,0N+t+u)-λj0(τ~j,0N+t)|+N-1j=1IN(0)|λ¯(τ~j,0N+t+u)-λ¯(τ~j,0N+t)|=:Δ0N,1(t,u)+Δ0N,2(t,u).

Then by Assumption 2.2, writing λj0(t)==1kλj0,(t)1[ζj-1,ζj)(t), we have

Δ0N,1(t,u)=N-1j=1IN(0)|=1kλj0,(τ~j,0N+t+u)1[ζj-1,ζj)(τ~j,0N+t+u)-=1kλj0,(τ~j,0N+t)1[ζj-1,ζj)(τ~j,0N+t)|N-1j=1IN(0)=1k|λj0,(τ~j,0N+t+u)-λj0,(τ~j,0N+t)|1ζj-1τ~j,0N+tτ~j,0N+t+uζj+λN-1j=1IN(0)=1k1τ~j,0N+tζjτ~j,0N+t+uφ(u)I¯N(0)+λN-1=1kj=1IN(0)1τ~j,0N+tζjτ~j,0N+t+u. 5.28

Both terms on the right hand side are increasing in u, and thus, we have

sup0uδΔ0N,1(t,u)φ(δ)I¯N(0)+λN-1=1kj=1IN(0)1τ~j,0N+tζjτ~j,0N+t+δ.

Here for the second term, we have

N-1=1kj=1IN(0)1τ~j,0N+tζjτ~j,0N+t+δ=N-1=1kj=1IN(0)[1τ~j,0N+tζjτ~j,0N+t+δ-(F(τ~j,0N+t+δ)-F(τ~j,0N+t)))]+N-1=1kj=1IN(0)(F(τ~j,0N+t+δ)-F(τ~j,0N+t))),

hence

PN-1=1kj=1IN(0)1τ~j,0N+tζjτ~j,0N+t+δ>ϵ=1kPN-1j=1IN(0)[1τ~j,0N+tζjτ~j,0N+t+δ-(F(τ~j,0N+t+δ)-F(τ~j,0N+t)))]>ϵ/2k+=1kPN-1j=1IN(0)(F(τ~j,0N+t+δ)-F(τ~j,0N+t)))>ϵ/2k. 5.29

The first term on the right of (5.29) tends to 0 as N, since by conditioning on σ{IN(0,y):0yx¯}=σ{τ~j,0N,j=1,,IN(0)}, and since the ζj’s are mutually independent and globally independent of the τ~j,0N’s, we obtain

E[(N-1j=1IN(0)(1τ~j,0N+tζjτ~j,0N+t+δ-(F(τ~j,0N+t+δ)-F(τ~j,0N+t))))2]=E[N-10x¯(F(y+t+δ)-F(y+t)))[1-(F(y+t+δ)-F(y+t)))]I¯N(0,dy)].

The second term on the right of (5.29) equals

=1kP0x¯(F(y+t+δ)-F(y+t)))I¯N(0,dy)>ϵ/2k,

whose limsup as N is bounded from above by

=1k10x¯(F(y+t+δ)-F(y+t)))I¯(0,dy)ϵ/2k.

Since for each 1k,

δ0x¯(F(y+t+δ)-F(y+t)))I¯(0,dy)

is continuous and equals 0 at δ=0, for any ϵ>0, there exists δ>0 small enough such that the above quantity vanishes. Thus, we have shown that

lim supNsupt[0,T]1δPsup0uδΔ0N,1(t,u)>ϵ/30,asδ0. 5.30

Next, consider Δ0N,2(t,u), which is Δ0N,1(t,u), with the j-th term in the absolute value being replaced by its conditional expectation given τ~j,0N. The computations which led above to (5.28) give

sup0uδΔ0N,2(t,u)φ(δ)I¯N(0)+λN-1=1kj=1IN(0)(F(τ~j,0N+t+δ)-F(τ~j,0N+t)).

So the same arguments as those used above yield that (5.30) holds with Δ0N,1(t,u) replaced by Δ0N,2(t,u).

Thus we have shown that in probability, Ξ¯0N0 in D as N. The convergence Ξ¯1N0 in D in probability follows from the proof of Lemma 4.6 in [10]. In fact, the above proof of Ξ¯0N0 can be adapted to that proof by observing the similar roles of AN and IN(0,·). This completes the proof.

Lemma 5.9

Under Assumptions 2.1 and 2.2, along a convergent subsequence of A¯N which converges weakly to A¯,

I¯NI~inDasN, 5.31

where I~(t) is given by

I~(t)=0x¯λ¯(y+t)I¯(0,dy)+0tλ¯(t-s)dA¯(s),t0. 5.32

Proof

By the above lemma, it suffices to show that

I~NI~inDasN. 5.33

The expression of I~N in (5.27) can be rewritten as

I~N(t)=0x¯λ¯(y+t)I¯N(0,dy)+0tλ¯(t-s)dA¯N(s). 5.34

It follows from Lemma 5.1 that for any t>0, as N, I~N(t)I~(t). It remains to show that the sequence I~N is tight in D. For that purpose, exploiting the Corollary on page 83 of [4], it suffices to show that for any ϵ>0,

limδ0lim supN1δPsup0uδ0x¯λ¯(y+t+u)I¯N(0,dy)-0x¯λ¯(y+t)I¯N(0,dy)>ϵ=0, 5.35
limδ0lim supN1δPsup0uδ0t+uλ¯(t+u-s)dA¯N(s)-0tλ¯(t-s)dA¯N(s)>ϵ=0. 5.36

(5.35) follows from the fact that, with Gδ(s):=sup0uδ|λ¯(s+u)-λ¯(s)|,

lim supNPsup0uδ0x¯(λ¯(y+t+u)-λ¯(y+t))I¯N(0,dy)>ϵ10x¯Gδ(y+t)I¯(0,dy)>ϵ.

Now I¯(0,dy) a.e., Gδ(y+t)0, and since 0Gδ(y+t)λ, it follows from Lebesgue’s dominated convergence that 0x¯Gδ(y+t)I¯(0,dy)0, as δ0,hence for δ>0 small enough, this quantity is less than ϵ, and the indicator vanishes.

It remains to establish (5.36). We have

0t+uλ¯(t+u-s)dA¯N(s)-0tλ¯(t-s)dA¯N(s)=tt+uλ¯(t+u-s)dA¯N(s)+0t[λ¯(t+u-s)-λ¯(t-s)]dA¯N(s),

hence

sup0uδ0t+uλ¯(t+u-s)dA¯N(s)-0tλ¯(t-s)dA¯N(s)(λ)2δ+λ0tGδ(t-s)ds+λ|M¯AN(t+δ)-M¯AN(t)|+0tGδ(t-s)dM¯AN(s)

The result follows since the sum of the two first terms on the right are less than ϵ/2 for δ>0 small enough, while the two last terms tend to 0, as N.

Completing the Proof of Theorem 2.1

By Lemmas 5.2 and 5.5, we have that, along a subsequence,

I¯N(t,x)=I¯0N(t,x)+I¯1N(t,x)I~(t,x)=I¯0(t,x)+I¯1(t,x)DDasN,

where I¯0(t,x) and I¯1(t,x) are given in (5.2) and (5.17), respectively. Also recall that S¯N=S¯N(0)-A¯N by (2.9). We need to show the joint convergence

(S¯N,I¯N,I¯N)(S¯,I~,I~)inD×DD×DasN.

or equivalently,

(A¯N,I¯N,I¯N)(A¯,I~,I~)inD×DD×DasN. 5.37

Indeed, first thanks to Lemma 5.8, we can replace I¯N by I~N. Next we have the decompositions

I¯N=I¯0N+I¯1N,I~N=I~0N+I~1N,

where I~0N and I~1N are respectively the first and the second term on the right of the identity (5.34). By the independence of the quantities associated with initially and newly infected individuals, it suffices to prove the joint convergence of the processes (I¯0N,I~0N) and that of the processes (A¯N,I¯1N,I~1N) separately. We have proved in Lemma 5.2 that I¯0NI¯0 in DD in probability, and it follows from the arguments in the proof of Lemma 5.9 that I~0NI~0 in D in probability, where I~0 is the first term on the right of the identity (5.32). Hence, the joint convergence (I¯0N,I~0N)(I¯0,I~0) in D2 in probability is immediate.

Exploiting again (5.21), we see that the joint convergence (A¯N,I¯1N,I~1N)(A¯,I¯1,I~1) will be a consequence of

(A¯N,I˘1N,I~1N)(A¯,I¯1,I~1)inD×DD×DasN. 5.38

where I~1 denotes the second term on the right of the identity (5.32). Since I˘1N(t,x)=(t-x)+tFc(t-s)dA¯N(s) and I~1N(t)=0tλ¯(t-s)dA¯N(s), the joint finite dimensional convergence is a consequence of the continuous mapping theorem and Lemma 5.1. Hence the result follows from tightness. We have proved the joint convergence property in (5.37).

Recall the expression of Υ¯N(t)=S¯N(t)I¯N(t). Applying the continuous mapping theorem again, we obtain that

Υ¯N(t)Υ¯(t)=S¯(t)I~(t)inDasN.

Thus by (5.13), we conclude that

A¯NA¯=0·Υ¯(s)ds=0·S¯(s)I~(s)dsinDasN.

Therefore, the limit (S¯,I~) satisfies the set of integral equations in (2.13), (2.14) and the limit I~ coincides with I¯ defined by (2.14). Then, the limit I~ coincides with I¯ in (2.15). The limits I¯ in (2.18) and R¯ in (2.16) then follow immediately. The set of integral equations has a unique deterministic solution. Indeed, it is easy to see that the system of equations (2.13) and (2.14) (together with the first part of (2.17)) has a unique solution (S¯,I¯), given the initial values I¯(0,·). The other processes I¯,I¯,R¯ are then uniquely determined. Hence the whole sequence converges in probability.

From (2.15), we deduce that for all t>0,

I¯x(t,0)=limx0I¯(t,x)-I¯(t,0)x=limx0I¯(t,x)x=Υ¯(t).

This prove the second equality in (2.17).

It remains to prove the continuity. The continuity in t of S¯(t) is clear. Let us prove that tI¯(t) is continuous. Since λi is càdlàg and bounded, it is easily checked that tλ¯(t)=E[λ(t)] is also càdlàg. In fact it is continuous if all the F’s for 1k are continuous. The points of discontinuity of λ¯(t) are the points where one of the laws of the ζ has some mass. The set of those points is at most countable. Consequently, if tnt, the set of y’s where λ¯(tn+y) may not converge to λ¯(t+y) is at most countable, and this is a set of zero I¯(0,dy) measure. Since moreover 0λ¯(tn+y)λ, t0x¯λ¯(y+t)I¯(0,dy) is continuous. Let us now consider the second term in (2.14). We first note that since λ¯(t-s)λ and S¯(t)1, it follows from (2.14), (2.17) and Gronwall’s Lemma that I¯(t)λeλt. Let tnt. We have

0tλ¯(t-s)Υ¯(s)ds-0tnλ¯(tn-s)Υ¯(s)ds0t|λ¯(t-s)-λ¯(tn-s)|Υ(s)ds+(λ)2eλ(ttn)|t-tn|.

Clearly the above right hand side tends to 0, as n. A similar argument shows that R¯ and I¯ are continuous, and that (t,x)I¯(t,x) is continuous. Finally, since the convergence holds in D×D×DD×D and the limits are continuous, the convergence is locally uniform in t and x. This completes the proof of Theorem 2.1.

Acknowledgements

We thank the reviewers on the helpful comments that have improved the exposition of our paper. Guodong Pang is partly supported by the NSF grant DMS-2216765.

Appendix: Proof of Theorem 5.1

Given δ>0, we define the two sets

ΓT,δ:={0,δ,2δ,,Tδδ},ΓS,δ:={0,δ,2δ,,Sδδ}.

For any t[0,T], we define γT,δ(t) to be the element of ΓT,δ such that γT,δ(t)t<γT,δ(t)+δ, and for any s[0,S], we define γS,δ(s) to be the element of ΓS,δ such that γS,δ(s)s<γS,δ(s)+δ.

Let (ts) and (t,s) be two points in [0,T]×[0,S] such that |t-t||s-s|δ. We have

XN(t,s)-XN(t,s)=XN(t,s)-XN(t,γS,δ(s))+XN(t,γS,δ(s))-XN(γT,δ(t),γS,δ(s))+XN(γT,δ(t),γS,δ(s))-XN(γT,δ(t),γS,δ(s))+XN(γT,δ(t),γS,δ(s))-XN(γT,δ(t),γS,δ(s))+XN(γT,δ(t),γS,δ(s))-XN(t,γS,δ(s))+XN(t,γS,δ(s))-XN(t,s).

Hence

Psup0t,tT;0s,sS;|t-t||s-s|δ|XN(t,s)-XN(t,s)|>ϵ3sΓS,δPsup0tT,u[0,δ]|XN(t,s+u)-XN(t,s)|>ϵ/6+3tΓT,δPsup0sS,u[0,δ]|XN(t+u,s)-XN(t,s)|>ϵ/631δ+1sup0sSPsup0tT,u[0,δ]|XN(t,s+u)-XN(t,s)|>ϵ/6+31δ+1sup0tTPsup0sT,u[0,δ]|XN(t+u,s)-XN(t,s)|>ϵ/6.

It then follows from (ii) that, as δ0,

lim supNPsup0t,tT;0s,sS;|t-t||s-s|δ|XN(t,s)-XN(t,s)|>ϵ0.

This, combined with (i), implies the result.

Declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Guodong Pang, Email: gdpang@rice.edu.

Étienne Pardoux, Email: etienne.pardoux@univ-amu.fr.

References

  • 1.Aras AK, Liu Y, Whitt W. Heavy-traffic limit for the initial content process. Stoch. Syst. 2017;7(1):95–142. doi: 10.1287/15-SSY175. [DOI] [Google Scholar]
  • 2.Balan, R.M., Saidani, B.: Weak convergence and tightness of probability measures in an abstract skorohod space. arXiv preprint arXiv:1907.10522 (2019)
  • 3.Bickel PJ, Wichura MJ. Convergence criteria for multiparameter stochastic processes and some applications. Ann. Math. Stat. 1971;42(5):1656–1670. doi: 10.1214/aoms/1177693164. [DOI] [Google Scholar]
  • 4.Billingsley P. Convergence of Probability Measures. New York: Wiley; 1999. [Google Scholar]
  • 5.Britton T, Pardoux E. Stochastic epidemics in a homogeneous community. In: Britton T, Pardoux E, editors. Stochastic Epidemic Models with Inference. Part I. Lecture Notes in Mathematics. Amsterdam: Elsevier; 2019. pp. 1–120. [Google Scholar]
  • 6.Chen Y, Yang J, Zhang F. The global stability of an SIRS model with infection age. Math. Biosci. Eng. 2014;11(3):449–469. doi: 10.3934/mbe.2014.11.449. [DOI] [PubMed] [Google Scholar]
  • 7.Çinlar E. Probability and Stochastics. Berlin: Springer; 2011. [Google Scholar]
  • 8.Clémençon S, Chi Tran V, De Arazoza H. A stochastic SIR model with contact-tracing: large population limits and statistical inference. J. Biol. Dyn. 2008;2(4):392–414. doi: 10.1080/17513750801993266. [DOI] [PubMed] [Google Scholar]
  • 9.Duchamps, J.-J., Foutel-Rodier, F., Schertzer, E.: General epidemiological models: Law of large numbers and contact tracing. arXiv preprint arXiv:2106.13135 (2021)
  • 10.Forien R, Pang G, Pardoux É. Epidemic models with varying infectivity. SIAM J. Appl. Math. 2021;81(5):1893–1930. doi: 10.1137/20M1353976. [DOI] [Google Scholar]
  • 11.Forien R, Pang G, Pardoux É. Estimating the state of the Covid-19 epidemic in France using a model with memory. R. Soc. Open Sci. 2021;8:2023273. doi: 10.1098/rsos.202327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Foutel-Rodier F, Blanquart F, Courau P, Czuppon P, Duchamps J-J, Gamblin J, Kerdoncuff É, Kulathinal R, Régnier L, Vuduc L, et al. From individual-based epidemic models to McKendrick–von Foerster PDEs: a guide to modeling and inferring COVID-19 dynamics. J. Math. Biol. 2022;85:43. doi: 10.1007/s00285-022-01794-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gaubert S, Akian M, Allamigeon X, Boyet M, Colin B, Grohens T, Massoulié L, Parsons DP, Adnet F, Chanzy É, et al. Understanding and monitoring the evolution of the Covid-19 epidemic from medical emergency calls: the example of the paris area. Comptes Rendus. Math. 2020;358(7):843–875. doi: 10.5802/crmath.99. [DOI] [Google Scholar]
  • 14.Hoppensteadt F. An age dependent epidemic model. J. Franklin Inst. 1974;297(5):325–333. doi: 10.1016/0016-0032(74)90037-4. [DOI] [Google Scholar]
  • 15.Inaba H. Kermack and McKendrick revisited: the variable susceptibility model for infectious diseases. Jpn. J. Ind. Appl. Math. 2001;18(2):273–292. doi: 10.1007/BF03168575. [DOI] [Google Scholar]
  • 16.Inaba H, Sekine H. A mathematical model for Chagas disease with infection-age-dependent infectivity. Math. Biosci. 2004;190(1):39–69. doi: 10.1016/j.mbs.2004.02.004. [DOI] [PubMed] [Google Scholar]
  • 17.Kaplan EH. OM Forum-COVID-19 scratch models to support local decisions. Manuf. Serv. Oper. Manag. 2020;22(4):645–655. doi: 10.1287/msom.2020.0891. [DOI] [Google Scholar]
  • 18.Kermack W O, McKendrick A G. A contribution to the mathematical theory of epidemics. Proc. R. Soc. Lond. Ser. A. 1927;115(772):700–721. doi: 10.1098/rspa.1927.0118. [DOI] [Google Scholar]
  • 19.Kermack W O, McKendrick A G. Contributions to the mathematical theory of epidemics. II. The problem of endemicity. Proc. R. Soc. Lond. Ser. A. 1932;138(834):55–83. doi: 10.1098/rspa.1932.0171. [DOI] [Google Scholar]
  • 20.Kermack W O, McKendrick A G. Contributions to the mathematical theory of epidemics. III. Further studies of the problem of endemicity. Proc. R. Soc. Lond. Ser. A. 1933;141(843):94–122. doi: 10.1098/rspa.1933.0106. [DOI] [Google Scholar]
  • 21.Khoshnevisan D. Multiparameter Processes: An Introduction to Random Fields. Berlin: Springer Science & Business Media; 2002. [Google Scholar]
  • 22.Magal P, McCluskey C. Two-group infection age model including an application to nosocomial infection. SIAM J. Appl. Math. 2013;73(2):1058–1095. doi: 10.1137/120882056. [DOI] [Google Scholar]
  • 23.Martcheva M. An Introduction to Mathematical Epidemiology. Berlin: Springer; 2015. [Google Scholar]
  • 24.Pang G, Pardoux E. Functional central limit theorems for epidemic models with varying infectivity. Stochastics. 2022 doi: 10.1080/17442508.2022.2124870. [DOI] [Google Scholar]
  • 25.Pang G, Pardoux É. Functional limit theorems for non-Markovian epidemic models. Ann. Appl. Probab. 2022;32(3):1615–1665. doi: 10.1214/21-AAP1717. [DOI] [Google Scholar]
  • 26.Pang G, Whitt W. Two-parameter heavy-traffic limits for infinite-server queues. Queueing Syst. 2010;65(4):325–364. doi: 10.1007/s11134-010-9184-z. [DOI] [Google Scholar]
  • 27.Pang G, Zhou Y. Two-parameter process limits for an infinite-server queue with arrival dependent service times. Stoch. Process. Appl. 2017;127(5):1375–1416. doi: 10.1016/j.spa.2016.08.003. [DOI] [Google Scholar]
  • 28.Thieme HR, Castillo-Chavez C. How may infection-age-dependent infectivity affect the dynamics of HIV/AIDS? SIAM J. Appl. Math. 1993;53(5):1447–1479. doi: 10.1137/0153068. [DOI] [Google Scholar]
  • 29.Zhang Z, Peng J. A SIRS epidemic model with infection-age dependence. J. Math. Anal. Appl. 2007;331:1396–1414. doi: 10.1016/j.jmaa.2006.09.061. [DOI] [Google Scholar]
  • 30.Zoltan Fodor, S.D.K., Kovacs, T.G.: Why integral equations should be used instead of differential equations to describe the dynamics of epidemics. arXiv:2004.07208 (2020)

Articles from Applied Mathematics and Optimization are provided here courtesy of Nature Publishing Group

RESOURCES